Surgical aspects in the treatment of lung cancer

Current Opinion in Pulmonary Medicine
Thomas V Bilfinger

Abstract

The treatment of lung cancer has been most successful when surgery is involved. This review is a succinct overview of lung cancer treatment from the thoracic surgeon's perspective over the past 2 years. Starting with the evidence-based guidelines developed by the American College of Chest Physicians, the main themes in the literature are a multimodality approach and the miniaturization of surgical approaches. Palliative procedures, staging, and extension of surgery to patients previously thought inoperable are other subjects covered. We are standing on the verge of having a definitive answer to the 20-year-old question whether adjuvant or neoadjuvant chemotherapy benefits patients with early-stage non-small cell lung cancer. Sufficient data will be available shortly to determine whether minimally invasive surgical approaches yield similar long-term outcomes as traditional approaches.

References

Mar 27, 1998·Chest·I G DuarteJ I Miller
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alain DepierreUNKNOWN French Thoracic Cooperative Group
Feb 5, 2002·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Martin HürtgenPeter Fritz
Feb 19, 2002·American Journal of Respiratory and Critical Care Medicine·Stephen J SwensenPeter C Pairolero
May 23, 2002·The Annals of Thoracic Surgery·Emmanuel MartinodJacques F Azorin
Jun 6, 2002·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·P ThomasR Giudicelli
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Stephen G Spiro, Joanna C Porter
Nov 26, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Koji KishiTakeshi Matsuoka
Jan 16, 2003·Chest·W Roy Smythe, UNKNOWN American College of Chest Physicians
Jan 16, 2003·Chest·Frank C DetterbeckUNKNOWN American College of Physicians
Feb 11, 2003·Chest·Hiroaki NomoriKeiichi Suemasu
Mar 21, 2003·The Annals of Thoracic Surgery·Gianfranco Buccheri, Domenico Ferrigno
Apr 10, 2003·The Annals of Thoracic Surgery·Richard I WhyteQuynh-Thu Le
Apr 17, 2003·The Journal of Thoracic and Cardiovascular Surgery·Luis J HerreraJames D Luketich
Apr 25, 2003·The British Journal of Radiology·O SchaeferM Langer
May 9, 2003·The Annals of Thoracic Surgery·Giuseppe CardilloMassimo Martelli
May 22, 2003·The New England Journal of Medicine·Alfred FishmanUNKNOWN National Emphysema Treatment Trial Research Group
Jun 5, 2003·Current Oncology Reports·Katherine M W Pisters
Jun 28, 2003·The Journal of Thoracic and Cardiovascular Surgery·Chao-Hua ChiuShi-Chuan Chang
Aug 13, 2003·Respiratory Care Clinics of North America·Katherine M W Pisters
Sep 13, 2003·Chest·Marco AlifanoJean François Regnard
Oct 8, 2003·The Annals of Thoracic Surgery·Farid GharagozlooE Pendleton Alexander
Nov 19, 2003·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Teruaki KoikeKeiichi Honma
Dec 23, 2003·The Journal of Thoracic and Cardiovascular Surgery·Gonzalo V Gonzalez-StawinskiThomas A D'Amico
Dec 23, 2003·The Journal of Thoracic and Cardiovascular Surgery·Carolyn E ReedUNKNOWN American College of Surgeons Oncology Group Z0050 trial
Jan 14, 2004·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Akitoshi Tatsumi, Yoshiaki Ueda
Jan 23, 2004·The New England Journal of Medicine·Rodrigo ArriagadaUNKNOWN International Adjuvant Lung Cancer Trial Collaborative Group
Mar 9, 2004·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Masaki TomitaKoichiro Shibata

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.